{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:25:29Z","timestamp":1794349529375,"version":"4.9.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23J21900500"],"award-info":[{"award-number":["23J21900500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009002","name":"Shanghai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.isci.2026.117390","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:59:48Z","timestamp":1791233988000},"page":"117390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4796-347X","authenticated-orcid":false,"given":"Haixia","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117390_bib1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117390_bib2","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.ymthe.2024.05.039","article-title":"Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies","volume":"32","author":"Al Hadidi","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.117390_bib3","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.bbmt.2018.12.068","article-title":"Clinical utilization of chimeric antigen receptor T cells in B cell acute lymphoblastic leukemia: An expert opinion from the European society for blood and marrow transplantation and the American society for blood and marrow transplantation","volume":"25","author":"Kansagra","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.isci.2026.117390_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jcyt.2013.06.003","article-title":"Simplified process for the production of anti\u2013CD19-CAR\u2013engineered T cells","volume":"15","author":"Tumaini","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.isci.2026.117390_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1389201019666180418095526","article-title":"CAR T-cell therapy: A new era in cancer immunotherapy","volume":"19","author":"Miliotou","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.isci.2026.117390_bib6","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1158\/1078-0432.CCR-18-2743","article-title":"FDA approval summary: Axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma","volume":"25","author":"Bouchkouj","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117390_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00262-014-1568-1","article-title":"Engineered T cells for cancer therapy","volume":"63","author":"June","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2026.117390_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413685","article-title":"Current non-viral-based strategies to manufacture CAR-T cells","volume":"25","author":"Gehrke","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117390_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.it.2019.02.005","article-title":"Elusive neurotoxicity in T cell-boosting anticancer therapies","volume":"40","author":"Zheng","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2026.117390_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202312153","article-title":"Nanoplatform-based in vivo gene delivery systems for cancer therapy","volume":"20","author":"Luo","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.isci.2026.117390_bib11","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2026.117390_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.molmed.2025.05.011","article-title":"Technologies for chimeric antigen receptor transgene delivery","volume":"31","author":"Xiao","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.isci.2026.117390_bib13","article-title":"mRNA-engineered CD5-CAR-\u03b3\u03b4TCD5- cells for the immunotherapy of T-cell acute lymphoblastic leukemia","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.117390_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0170","article-title":"Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies","volume":"2","author":"Beatty","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.117390_bib15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1089\/hum.2011.070","article-title":"Treatment of advanced leukemia in mice with mRNA engineered T cells","volume":"22","author":"Barrett","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.isci.2026.117390_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70140","article-title":"Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR","volume":"15","author":"Lam","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.isci.2026.117390_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101139","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.isci.2026.117390_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.accounts.1c00601","article-title":"Non-liver mRNA Delivery","volume":"55","author":"Loughrey","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.isci.2026.117390_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2019.05.032","article-title":"Therapeutic mRNA delivery to leukocytes","volume":"305","author":"Granot-Matok","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117390_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1525-0016(03)00184-9","article-title":"Femtosecond infrared laser\u2014an efficient and safe in vivo gene delivery system for prolonged expression","volume":"8","author":"Zeira","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.117390_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2018.02.043","article-title":"Cationic polymers for non-viral gene delivery to human T cells","volume":"282","author":"Olden","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117390_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/scd.2007.0209","article-title":"A simple and reliable electroporation method for human bone marrow mesenchymal stem cells","volume":"17","author":"Helledie","year":"2008","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.isci.2026.117390_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2019.04.040","article-title":"Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy","volume":"458","author":"Mukalel","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.117390_bib24","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ymthe.2022.02.026","article-title":"Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells","volume":"30","author":"El-Kharrag","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.117390_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12951-018-0401-y","article-title":"Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles","volume":"16","author":"Yasar","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.isci.2026.117390_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41467-017-00505-8","article-title":"Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers","volume":"8","author":"Moffett","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117390_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nano.2015.11.001","article-title":"Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines","volume":"12","author":"D\u00e9moulins","year":"2016","journal-title":"Nanomedicine."},{"key":"10.1016\/j.isci.2026.117390_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.117390_bib29","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/s41467-025-60959-z","article-title":"Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol","volume":"16","author":"Johansson","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117390_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125240","article-title":"Intracellular trafficking of lipid nanoparticles is hindered by cholesterol","volume":"671","author":"Luo","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.117390_bib31","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/mt.2016.179","article-title":"The Niemann-Pick C1 inhibitor NP3.47 enhances gene silencing potency of lipid nanoparticles containing siRNA","volume":"24","author":"Wang","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.117390_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00894-025-06308-9","article-title":"In silico insights into the membrane disruption induced by the protonation of ionizable lipids","volume":"31","author":"Zhao","year":"2025","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.isci.2026.117390_bib33","doi-asserted-by":"crossref","first-page":"9915","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117390_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.70007","article-title":"Engineering lipid nanoparticles for mRNA immunotherapy","volume":"17","author":"Zwolsman","year":"2025","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.isci.2026.117390_bib35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/20415990.2025.2506977","article-title":"The role of excipients in lipid nanoparticle metabolism: implications for enhanced therapeutic effect","volume":"16","author":"Knaggs","year":"2025","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.isci.2026.117390_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s42004-025-01699-5","article-title":"Spotlighting the criticality of lipid quality control through a mechanistic investigation of mRNA activity loss in lipid nanoparticles","volume":"8","author":"Kang","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.isci.2026.117390_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12032-025-02939-3","article-title":"Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy","volume":"42","author":"Abaza","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.isci.2026.117390_bib38","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2026.117390_bib39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.117390_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.smim.2017.08.015","article-title":"Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics\u2014An innate immune system standpoint","volume":"34","author":"Granot","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.isci.2026.117390_bib41","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.nanolett.8b01101","article-title":"Lipid nanoparticle formulations for enhanced co-delivery of siRNA and mRNA","volume":"18","author":"Ball","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2026.117390_bib42","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","article-title":"Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA","volume":"17","author":"Patel","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2026.117390_bib43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117390_bib44","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.analchem.4c00031","article-title":"Analytical characterization of heterogeneities in mRNA-lipid nanoparticles using sucrose density gradient ultracentrifugation","volume":"96","author":"Vaidya","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.isci.2026.117390_bib45","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1093\/nar\/gkx135","article-title":"N1-methyl-pseudouridine in mRNA enhances translation through eIF2\u03b1-dependent and independent mechanisms by increasing ribosome density","volume":"45","author":"Svitkin","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.117390_bib46","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/wrna.1510","article-title":"The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark","volume":"10","author":"Trixl","year":"2019","journal-title":"WIREs RNA"},{"key":"10.1016\/j.isci.2026.117390_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.117390_bib48","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1021\/acsnano.6b08447","article-title":"Structurally programmed assembly of translation initiation nanoplex for superior mRNA delivery","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2026.117390_bib49","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.117390_bib50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41422-022-00759-y","article-title":"LilrB3 is a putative cell surface receptor of APOE4","volume":"33","author":"Zhou","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2026.117390_bib51","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1021\/acsnano.4c16562","article-title":"Apolipoprotein fusion enables spontaneous functionalization of mRNA lipid nanoparticles with antibody for targeted cancer therapy","volume":"19","author":"Park","year":"2025","journal-title":"ACS Nano"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226027689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226027689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:56:49Z","timestamp":1794347809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226027689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589004226027689"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117390","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117390"}}